Could Mesa Laboratories, Inc. (MLAB) See a Reversal After Breaking All Highs?

Mesa Laboratories, Inc. (NASDAQ:MLAB) Logo

Investors sentiment increased to 1.45 in Q4 2018. Its up 0.18, from 1.27 in 2018Q3. It improved, as 7 investors sold Mesa Laboratories, Inc. shares while 31 reduced holdings. 16 funds opened positions while 39 raised stakes. 2.88 million shares or 9.59% more from 2.63 million shares in 2018Q3 were reported.
Ameriprise Fincl reported 59,357 shares stake. Yorktown Mngmt And Rech accumulated 4,157 shares or 0.29% of the stock. Moreover, Aqr Mgmt Ltd Liability has 0% invested in Mesa Laboratories, Inc. (NASDAQ:MLAB) for 2,519 shares. Goldman Sachs Group, a New York-based fund reported 1,939 shares. Metropolitan Life Insur holds 0.01% or 1,151 shares. Wasatch Advisors stated it has 26,674 shares or 0.07% of all its holdings. Sit Inv Associates accumulated 0.01% or 1,600 shares. Bancorp Of Montreal Can owns 64 shares or 0% of their US portfolio. Royal Comml Bank Of Canada stated it has 10,111 shares. Bluemountain Capital Mgmt Limited Liability Corp invested 0% in Mesa Laboratories, Inc. (NASDAQ:MLAB). Comerica Natl Bank holds 0.02% of its portfolio in Mesa Laboratories, Inc. (NASDAQ:MLAB) for 11,304 shares. King Luther Cap Corporation reported 43,821 shares. Price T Rowe Assocs Md holds 0.01% or 286,347 shares. National Bank & Trust Of Ny Mellon stated it has 0% of its portfolio in Mesa Laboratories, Inc. (NASDAQ:MLAB). 2,277 were accumulated by Neuberger Berman Gru Ltd.

Since December 4, 2018, it had 0 buys, and 7 selling transactions for $7.26 million activity. Shares for $750,687 were sold by GUILLEMIN EVAN. $581,750 worth of stock was sold by Schmieder John Bradley on Friday, February 8. Dwyer Robert V sold $959,623 worth of stock or 4,083 shares.

The stock of Mesa Laboratories, Inc. (NASDAQ:MLAB) reached all time high today, May, 8 and still has $280.93 target or 9.00 % above today’s $257.73 share price. This indicates more upside for the $997.03 million company. This technical setup was reported by If the $280.93 PT is reached, the company will be worth $89.73 million more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events.

The stock decreased 0.16% or $0.42 during the last trading session, reaching $257.73. About 14,071 shares traded. Mesa Laboratories, Inc. (NASDAQ:MLAB) has risen 90.17% since May 8, 2018 and is uptrending. It has outperformed by 85.80% the S&P500.

Analysts await Mesa Laboratories, Inc. (NASDAQ:MLAB) to report earnings on June, 4. They expect $1.96 EPS, down 10.09 % or $0.22 from last year’s $2.18 per share. MLAB’s profit will be $7.58M for 32.87 P/E if the $1.96 EPS becomes a reality. After $1.69 actual EPS reported by Mesa Laboratories, Inc. for the previous quarter, Wall Street now forecasts 15.98 % EPS growth.

More notable recent Mesa Laboratories, Inc. (NASDAQ:MLAB) news were published by: which released: “Marvell (MRVL) to Report Q4 Earnings: What’s in the Cards? – Yahoo Finance” on March 04, 2019, also with their article: “Amazon’s Move Against MongoDB Doesn’t Worry Me – Motley Fool” published on January 31, 2019, published: “CSIQ vs. RUN: Which Stock Is the Better Value Option? – Yahoo Finance” on February 08, 2019. More interesting news about Mesa Laboratories, Inc. (NASDAQ:MLAB) were released by: and their article: “Mesa Labs Acquires Canada’s Infitrak Inc. Nasdaq:MLAB – GlobeNewswire” published on July 06, 2015 as well as‘s news article titled: “Call Buyers Blitz Electronic Arts After New Apex Legends Numbers – Yahoo Finance” with publication date: February 12, 2019.

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products. The company has market cap of $997.03 million. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness. It has a 98.97 P/E ratio. This segment's products are used in healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, environmental air sampling, and semiconductor industries.

Mesa Laboratories, Inc. (NASDAQ:MLAB) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.